USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ADVANCED BREATH DIAGNOSTICS, LLC
Address:
ADVANCED BREATH DIAGNOSTICS, LLC
105 WESTPARK DR, STE 150
BRENTWOOD, TN 37027
Phone:
(615) 376-5464
URL:
N/A
EIN:
134111382
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $0.00 1
SBIR Phase II $749,674.00 1

Award List:

Improved Outcome Prediction In Galactosemic Newborns

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$749,674.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Galactosemia is a potentially lethal, but preventable, disease of newborns. In Phase I of this grant, we demonstrated that a 13C-galactose breath test could be used to assess the degree of impairment of whole body galactose oxidation in more than 90 galactosemic… More

Improved Outcome Prediction In Galactosemic Newborns

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Galactosemia is a potentially lethal, but preventable, disease of newborns. In Phase I of this grant, we demonstrated that a 13C-galactose breath test could be used to assess the degree of impairment of whole body galactose oxidation in more than 90 galactosemic… More